Competing in the U.S. Contract Research Market

 

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

This study encompasses vital feedback provided by outsourcing decision makers within pharmaceutical and biotechnology companies allowing CROs to gain insight into current and future outsourcing patterns and trends. Through the analysis provided, CROs will better be able to understand motives and perceived benefits of outsourcing, criteria for CRO selection and current and future technology requirements. Additionally, competitive factors across CROs are analyzed with a special focus on leading CROs. An analysis of clinical trial trends and patterns across regions will allow CROs to understand where future growth opportunities may lie and allow them to further penetrate this dynamic and lucrative market.

Table of Contents

Competing in the U.S. Contract Research Market, Competing in the U.S. Contract Research MarketIntroductionTitleDisclaimerCertificationTable of ContentsExecutive SummaryCompeting in the U.S. CRO MarketObjectives and MethodologyObjectives of the StudyMethodologyOutsourcing Patterns and TrendsPercent of Pharmaceutical and Biotechnology Outsourcing - By Research AreaPercent Clinical Development Outsourcing: Current and FutureResearch and Development BudgetPercent R&D Budget Allocated to CRO ExpendituresPercent Increase in CRO Budget Next 12-24 MonthsPercent Share of Phases in CRO Budget - Current and ProjectedMotives and Perceived Benefits of OutsourcingPerceived Benefits of OutsourcingCRO Utilization Satisfaction and PreferencesOncologyCentral Nervous System (CNS)CardiovascularMetabolic DiseasesInfectious DiseasesRespiratory/AllergyMusculoskeletal/ArthritisFull-Service CRO PreferencesNiche CRO PreferencesPre-Clinical Phase PreferencesPhase I PreferencesPhase II/III PreferencesPhase IV PreferencesMarket Segments and Criteria for CRO SelectionOverall Criteria for CRO Selection (Satisfiers)Areas for Improvement: Current Top Sources of DissatisfactionDerived vs. Stated ImportanceDerived vs. Stated Importance: Strategic IssuesDerived vs. Stated Importance: Secret IssuesDerived vs. Stated Importance: Non-IssuesDerived vs. Stated Importance: Basic RequirementsMarket Segments - The 3 Types of CRO Services UsersCriteria for CRO Selection by Market SegmentScope and Intensity of Outsourcing by Market SegmentPerceived Benefits and Motives for Outsourcing by Market SegmentR&D Budget Size by Market SegmentCRO Budget Share of the R&D Budget by Market SegmentCRO Preference MetricsThe Importance of CRO Performance MetricsPerceived Attributes of CROsRelative Perceived Strengths of CROs - The Broad Competitive LandscapeAn Evaluation of 11 Large CROsBrand Awareness and Preference of 11 Large CROsBrand Awareness of 11 Large CROsBrand Preference of 11 Large CROsAwareness and Conversion to Preference: 11 Large CROsA Note: The Potential Impact of the Acquisition of Charles River's Capabilities by KendleService Category vs Price Category MatrixService Category vs. Price Category Matrix: The Value FrontierRelative Perceived Strengths of 11 Large CROsClinical Trial Trends Across RegionsClinical Trials Per Region - Current and Future 2006-2011Other Technology Requirements: Current and FutureBiomarkers Biologics and Biotechnology Needs - Current and FutureIT Capabilities Expected from CROs - Current and FuturePurchase Behavior Patterns and TrendsAverage No. of CROs Invited per Request for Proposal (RFP) - By PhaseShare of Outstanding Budget Among Most Utilized CROsUtilization of Data Collection Capabilities in Phase II-IV TrialsStatus of Pre-Clinical Drug Discovery Outsourcing to CROsEmerging Factors for Future CRO Selection - Next 5 YearsAbout Frost & SullivanFrost & Sullivan




Related Research

Release Date : 20-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 18-Sep-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.